
Prisys is the leading innovator in
non-human primate disease modeling based on the capstone
platform along with global innovation-centered collaborations,
delivering never before solidified data package of translational
science and transformational technologies for new medicine and therapeutics in
advancement.
The
translational medicine calls for the meaningful connections, with both more
direct bidirectional and translatable means, to minimize the gap between
research and clinic. Prisys has never before in the world established a new and
integrated NHP platform composed of NHP disease models, relevant clinical diagnosis,
procedures, treatment, and measurements for global pharmas’ advancement of new medicines
and biotechnologies. It surpasses the rodents or the ex-patient materials by bringing
in more systemic and interpretable results to support more direct translation and
prediction of the applications in human.